Healthcare - Biotechnology - NASDAQ - US
$ 0.519
-12.1 %
$ 32.1 M
Market Cap
-0.38
P/E
BALANCE SHEET
151 M
ASSETS
39.3 M
LIABILITIES
111 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Passage Bio, Inc.
| Current Assets | 118 M |
| Cash & Short-Term Investments | 114 M |
| Receivables | 0 |
| Other Current Assets | 3.66 M |
| Non-Current Assets | 32.6 M |
| Long-Term Investments | 0 |
| PP&E | 32.2 M |
| Other Non-Current Assets | 433 K |
| Current Liabilities | 16.3 M |
| Accounts Payable | 1.3 M |
| Short-Term Debt | 6.75 M |
| Other Current Liabilities | 8.3 M |
| Non-Current Liabilities | 22.9 M |
| Long-Term Debt | 22.9 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 21.7 | 34.6 | 129.0 | 135.0 | 158.9 | 24.9 |
| Short Term Investments | 92.6 | 155.0 | 186.8 | 169.8 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 3.7 | 7.4 | 9.3 | 12.4 | 6.9 | 8.5 |
| Total Current Assets | 118.0 | 197.0 | 325.1 | 317.2 | 165.8 | 33.4 |
| PP&E | 32.2 | 42.2 | 23.8 | 2.8 | 1.1 | 28 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.4 | 4.3 | 6.2 | 5.2 | 11.8 | 34 K |
| Other Assets | 0 | 0 | 0 | 2.8 | 0 | 0 |
| Total Assets | 150.5 | 243.5 | 355.1 | 328.0 | 178.6 | 33.5 |
| LIABILITIES | ||||||
| Accounts Payable | 1.3 | 4.1 | 9.4 | 5.3 | 0.6 | 0.2 |
| Short Term Debt | 6.7 | 6.5 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.3 | 7.7 | 20.1 | 15.9 | 3.1 | 95 K |
| Total Current Liabilities | 16.3 | 18.4 | 29.5 | 21.2 | 3.7 | 0.3 |
| Long Term Debt | 22.9 | 23.8 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 6.9 | 2.1 | 0.6 | 45.3 |
| Total Liabilities | 39.3 | 42.2 | 36.4 | 23.3 | 4.3 | 45.6 |
| EQUITY | ||||||
| Common Stock | 5 K | 5 K | 5 K | 4 K | 3 K | 2 K |
| Retained Earnings | (594.5) | (492.4) | (356.3) | (170.9) | (58.7) | (13.0) |
| Other Accumulative Comprehensive Income/Loss | 43 K | (1.0) | (0.4) | 12 K | (0.2) | 0 |
| Total Equity | 111.3 | 201.4 | 318.7 | 304.7 | 174.4 | (12.2) |
| Total Liabilities and Equity | 150.5 | 243.5 | 355.1 | 328.0 | 178.6 | 33.5 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 54.7 | 54.4 | 53.3 | 38.6 | 45.8 | 24.0 |